NCT03755141 2025-07-22
Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer
National Cancer Center, Korea
Phase 2 Completed
Clinical Trials
4 trialsNCT03296553 2022-01-27
Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.
National Institute of Cancerología
Phase 2 Completed
NCT01774760 2019-10-04
Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer
Turku University Hospital
Phase 2 Completed
NCT01296815 2015-07-27
Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Centro de Investigación en. Enfermedades Infecciosas, Mexico
Phase 2 Completed